Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For example, research shows that primary care physicians misdiagnosed 65.9% MedXtractor Corp.’s of patients with social anxiety disorder.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Veriheal

MARCH 23, 2022

A groundbreaking research initiative could completely transform the future of diabetes treatment. Published in Cannabis and Cannabinoid Research, the investigation suggests that female adults who consume cannabis “heavily” tend to have a reduced risk of developing diabetes. Well, for females, at least.

Research and Development 98

Research and Development Blood Pressure Treatment Cannabinoids 98

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. NEW YORK, July 27, 2021 — Clever Leaves Holdings Inc.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

The Herb Collective

AUGUST 1, 2023

Cannabis Indica, also known as Indian Hemp or simply Indica, is a highly preferred strain of the cannabis plant. In this blog post, we're going to explore the ten health benefits of Cannabis Indica that you need to know about. Pain Reduction: Cannabis Indica is a natural choice for individuals enduring chronic pain.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Cannabis is an ideal substance to use during the various stages of cancer treatment but most especially after chemotherapy.

Patients 98

Patients Research and Development Treatment Consumption 98

Sensi Seeds

DECEMBER 10, 2018

Cannabis Remains Prohibited Despite Legislative and Scientific Progress. Although cannabis remains a banned substance in many countries, over the past few decades the trend towards regulating its use for medical and therapeutic purposes has been consolidating globally. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JULY 8, 2021

A Swinburne study into the effects on medical cannabis on driving ability has received $358,980 in funding from the federal government’s Road Safety Innovation Fund. The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We Mirage News reports.

Medicine 98

Medicine Research and Development Safety THC 98

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs. Magnetic resonance imaging (MRI) is a vital diagnostic tool in the medical world.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. In Canada, mental health issues affect more than 6.7

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Veriheal

AUGUST 12, 2020

Cancer is the name that has been given to a collective of related diseases which can be present in any part of the human body. Conventional and experimental treatments for cancer often involve undesired, and sometimes extreme, side effects. Now, cannabis shows the promise of potentially curing cancer by attacking its cells. .

Strains 104

Strains Research and Development Treatment THC 104

The Cannigma

MARCH 2, 2021

Many US military veterans avoid speaking to a doctor before self-medicating with cannabis due to stigma and fear of consequences, potentially putting their health at risk, according to the findings of a new study. Reddit and the anonymity to talk about cannabis. ’ (Shutterstock).

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

DECEMBER 9, 2021

The study flagship site will be at John Hopkins University (JHU) with research led by Dr. Matthew Johnson. The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Veriheal

FEBRUARY 18, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as cannabis, psilocybin, and other psychedelics. But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

JULY 19, 2021

Our collaboration with the University of Milan is expected to afford us an incredible opportunity to, among other things, rigorously map out how cannabis strains behave throughout a full heat-not-burn temperature spectrum at incremental volumes inhaled,” said Jordan Medley, head of product operations at RYAH. Forward-Looking Statements.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

MARCH 6, 2019

PUBLISHER: CANNABIS LAW REPORT. I recently had the unbelievably good fortune to be a participant, attendee and a featured speaker at the Global Cannabis Business Development Conference held in Portland, Oregon last week. The collective IQ in that room was staggering! Cannabis Central LLC. AUTHOR: Rob Hendrix.

Business 51

Business Research and Development Treatment Collective 51

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc. How to Use the Data.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

SEPTEMBER 10, 2021

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc. ” The U.S.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Veriheal

DECEMBER 23, 2022

Cannabis prohibition is doing more than just creating a barricade between consumers and safe products. State Cannabis Contaminant Rules Vary Widely,” consumers have little choice but to purchase contaminated cannabis products. Researchers Inspected Cannabis Products for Contaminants. Led by Dr. Maxwell C.K.

Research and Development 92

Research and Development Agriculture Data Extraction 92

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Marijuana Dispensaries in Florida The emergence of marijuana dispensaries in Florida marks a pivotal moment in the state’s approach to medical cannabis.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Veriheal

MAY 17, 2023

On April 26, Singaporean authorities at Changi prison executed Singaporean Tamil national Tangaraju Suppiah, 46, who was purportedly involved in the trafficking of 1 kilogram of cannabis—a crime that his family believes he is innocent of committing. grams of cannabis in 2017.

Research and Development 96

Research and Development Medicine Treatment Epilepsy 96

Cannabis Law Report

JULY 21, 2021

The treatment is designed to target nociplastic pain originating in the central nervous system through the neuroplasticity benefits of psilocybin. Research Investigator, University of Michigan Department of Anesthesiology. Director of the Chronic Pain & Fatigue Research Center.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

SEPTEMBER 7, 2021

Perth-based medicinal cannabis producer Little Green Pharma (ASX: LGP) has taken delivery of the first shipment of cannabis flower medicines from its new growing facility in Denmark. Cannabis flower is frequently prescribed as a breakthrough pain treatment or to assist with sleep, due to its rapid onset of therapeutic benefit.

Seed-To-Sale 103

Seed-To-Sale Supply Chain Research and Development Medicine 103

Medicinal Genomics

JANUARY 10, 2024

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. Look no further than the CannMed Advisory Board for evidence that the most esteemed clinicians and researchers make the trip to CannMed each year.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

CannaMD

OCTOBER 6, 2020

As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. Yet with this recent breakthrough, cannabis has provided scientists with the new lead they’ve been looking for. Researchers also found that CBG destroyed drug-resistant host cells.

Research and Development 116

Research and Development Marijuana Cannabinoids Conditions 116

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. About Bionomics Limited. The post Bionomics Announces Plans to Conduct U.S.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

Veriheal

JULY 23, 2020

When we talk about cannabis legalization providing an opportunity for criminal justice reform that includes social equity – paying the cops with cannabis profits is definitely not what most had in mind. Thankfully, in Portland, Oregon officials will no longer use cannabis-derived tax funds for the city’s police budget.

Research and Development 98

Research and Development Safety Treatment Cannabis 98

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Like PTSD, TBI can have a profound impact on mental health.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Veriheal

JANUARY 15, 2024

Active research was carried out on the effects of these drug policies on society and the results, in these reports, have led the United Nations to consider a favorable revision of drug policies in order to protect human rights. 2023 World UN World Drug Report The 2023 World Drug Report urges the development of effective drug policies.

Policy 117

Policy Research and Development Collective Law 117

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Effective, most effective in treatment Relieve symptoms. Today (30 May) at 09.30

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

AUGUST 2, 2021

Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental healthcare. Collectively, the team applies a diligent, in-depth scientific approach to portfolio company selection, evaluation and monitoring.

Research and Development 98

Research and Development Therapy Collective Treatment 98